This is a working overview of HGF/c-Met, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-03-14. Anything still debated is marked as such rather than presented as settled.
Human data for dihexa remain absent from peer-reviewed clinical literature. As a result, questions about absorption, distribution, metabolism, excretion, and long-term safety are unresolved. Discussions often appear in nootropic forums, where anecdotal reports cannot substitute for controlled trials. Researchers have called for more rigorous pharmacokinetic and toxicological studies before any clinical evaluation. Until such data exist, dihexa is best described as an investigational research compound rather than a proven intervention.
The proposed mechanism for dihexa centers on hepatocyte growth factor, or HGF, and its receptor c-Met. HGF signaling is involved in cell growth, survival, and synapse formation. Dihexa has been described as an HGF mimetic or modulator in preclinical literature. Whether it binds c-Met directly, increases HGF availability, or acts through another route remains uncertain. This mechanistic uncertainty is a recurring theme in reviews of the compound, and no single molecular model has been confirmed across independent laboratories.
Research on dihexa has primarily used rodent models and cultured cells. Common endpoints include dendritic spine density, synaptic protein expression, and performance on maze or avoidance tasks. Some studies report improvements in cognitive measures after scopolamine-induced deficits or in aged animals. These findings are interesting but come from a small body of work, and independent laboratories have not consistently replicated all reported effects. Larger, preregistered studies would help clarify which results are robust.
Regulatory treatment varies by country. Dihexa does not appear in major pharmacopeias as a licensed therapeutic substance. Suppliers may use labels such as research use only or not for human consumption. Such labels reflect legal and quality-control boundaries rather than evidence of clinical benefit. Importation, possession, and sale can be restricted depending on local laws, and enforcement focuses on claims, distribution channels, and product categories. These rules can change, and they differ from rules for approved medicines.
Dihexa is a synthetic peptide studied in preclinical neuroscience. It is often described as an angiotensin IV analog or derivative. The compound also appears under research codes such as PNB-0408 and N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. It is not an approved drug, and it is not a conventional vitamin or nutrient. In many jurisdictions, material sold as dihexa is handled as a research chemical rather than a medicine or supplement. This classification affects how the material is labeled and distributed.
| Property | Value | Notes |
|---|---|---|
| Primary proposed target | HGF/c-Met signaling | Direct binding not confirmed |
| Research models | Rodent and cell studies | Preclinical only |
| Human clinical data | None published | Safety and efficacy unknown |
| Regulatory status | Unapproved research chemical | Status varies by country |
| Typical research purity | 95% or higher by HPLC | Depends on supplier and batch |
Discussion of dihexa in online communities sometimes outpaces the scientific record. Anecdotal reports are difficult to verify and may not distinguish effects from placebo or expectation. The absence of approved human data means long-term risks remain unknown. Researchers continue to investigate related compounds and pathways. Open questions include whether animal findings translate to humans and which biological targets matter most. No consensus exists on these points. Current reviews emphasize the need for rigorous clinical research.
Most published work on dihexa consists of preclinical studies using cell cultures or rodents. Reports have described effects on synaptic connectivity and performance on cognitive tasks in some animal models. These findings are generally presented as preliminary and require independent replication. Study designs, doses, and outcome measures vary across experiments, which complicates direct comparison. No large controlled human trials have established efficacy or safety for any medical use. At present, the evidence base is limited.
Regulatory agencies have not approved dihexa as a prescription drug or supplement. In many countries it falls into a gray area when sold for laboratory research. Buyers may encounter products marketed for research use only, which are not intended for human consumption. Purity and identity can vary between suppliers and batches. Certificates of analysis and independent testing are often recommended for research materials. Documentation helps verify what a vial contains.
Regulatory status differs by country, but dihexa is generally not approved as a therapeutic product. It is often sold as a research chemical, which means purity, labeling, and handling fall outside pharmaceutical drug standards. Some jurisdictions restrict the sale of peptides intended for human consumption. Researchers and suppliers may therefore face different legal requirements depending on location. Import rules and customs enforcement can also affect how such compounds move across borders.
Human safety data are sparse. No widely accepted dosing regimen, long-term safety profile, or clinical efficacy endpoint has been established. Published animal results can suggest directions for further study, but species differences and study design limit direct translation. Open questions include bioavailability, blood-brain barrier penetration, metabolism, and whether observed effects arise from a single target or multiple pathways. Replication across independent laboratories remains an important benchmark for evaluating the strength of preclinical claims.
Most published reports on dihexa come from cell cultures and animal models. Studies have examined markers of synapse formation, dendritic spine density, and performance on learning tasks in rodents. Proposed mechanisms center on hepatocyte growth factor and its c-Met receptor, with additional attention to angiotensin IV-related pathways. These findings are experimental and have not been confirmed as clinical benefits in humans. The literature often uses different tasks and endpoints, which complicates direct comparison across studies.
=== Hydride source === Formic acid shares some of the reducing properties of aldehydes, reducing solutions of metal oxides to their respective metal, and sulfur dioxide to thiosulfate via dithionite. In synthetic organic chemistry, it is often used as a source of hydride ion, as in the Eschweiler–Clarke reaction:
=== Background and theme === On January 9, 2020, American Horror Story was renewed for up to a thirteenth season. On December 5, 2018, Ryan Murphy said the witches from Coven would return in a future season. On July 28, 2026, Murphy announced in an interview with Entertainment Tonight that the season, officially titled 13, would consist of 13 episodes, and while the season would revisit Coven, it was not a direct sequel. He desribed it as an Avengers-style crossover between "all the seasons", with characters coming together "to defeat the ultimate evil", and added that he spent years writing it. Leslie Grossman explained that the series was set in one universe with different timelines, which "intersect in a way that makes sense". The theme of the number 13 was announced alongside the title. The show's official FX page for the season reads: "FX's American Horror Story ... returns for an unrivaled 13th installment that will do justice to everyone's most feared number. ... Which iconic horrors will return to haunt the hallowed halls of 13 and what new terrors await? Light your candles, draw your pentagrams and prepare for a supreme surprise." In August 2026, Murphy revealed he would direct an episode, for the first time since "Checking In" (2015). In September 2026, he said that the crossover with Scream Queens was planned to be included in the season, but it was scrapped after the departure of Ariana Grande, who was supposed to reprise her role as Chanel #2.
=== OMICS Genomics === Provides DNA sequencing and DNA fragmentation analysis services. Uses Sanger sequencing and next-generation sequencing (NGS) on Illumina MiSeq platforms. Offers quality control for DNA, RNA, and NGS libraries using instrumentation such as spectrophotometers, fluorometers, and Bioanalyzer systems.
Betamethasone dipropionate is a glucocorticoid steroid with anti-inflammatory and immunosuppressive properties. It is applied as a topical cream, ointment, lotion or gel (Diprolene) to treat itching and other skin conditions such as eczema. Minor side effects include dry skin and mild, temporary stinging when applied. Betamethasone dipropionate is a "super high potency" corticosteroid used to treat inflammatory skin conditions such as dermatitis, eczema and psoriasis. It is a synthetic analog of the adrenal corticosteroids. Although its exact mechanism of action is not known, it is effective when applied topically to cortico-responsive inflammatory dermatoses. It is available as a generic medication.
These vascular risk factors lead to ischemia (poor blood supply) to a portion of the optic disc. The disc then swells, and in a crowded optic disc, this leads to compression and more ischemia. GLP-1 agonists, a class of medications which are used to treat diabetes and obesity, appear to significantly increase the risk of developing NAION; however, further research is needed to establish if the observed association is a causal relationship. Since both eyes tend to have a similar shape, the optometrist or ophthalmologist will look at the good eye to assess the anatomical predisposition. The unaffected eye has a 14.7% risk of NAION within five years. A number of uncontrolled single case or small number of patient reports have associated NAION with use of oral erectile dysfunction drugs.
Sources: en.wikipedia.org
== See also == List of female scientists before the 20th century Lists of women in science Timeline of women in geology Timeline of women's education Timeline of women in computing Timeline of women in library science Timeline of women in mathematics in the United States Timeline of women in mathematics Timeline of women in science in the United States Women in physics
After neighbors reported the crime and named Karriem as a likely suspect, Karriem and wife Bertha (35) were arrested at 2729 Clinton street. In custody, Karriem admitted to the slayings. Karriem told police: "I had to kill somebody, I could not forsake my gods". Karriem reportedly told police "The ninth hour of the twentieth day had come Sunday. It was predestined 1,500 years ago that at that hour I must make a human sacrifice to my gods. It must not be a member of the Order of Islam." Karriem claimed Smith assented to the sacrifice, telling police "At first he didn't want to be killed, but when I showed him that he would be the saviour of the world and go to heaven right away, he said all right." Press on November 21 reported Karriem was the self-described "King" of a 100-member cult. Police initially suspected Karriem might be tied to the 1929 slaying of Benny Evangelista, whom press called a cult leader. Press ran a second story on the practice of Voodoo. Karriem explained "Smith was sitting in a chair in front of the altar. My wife was time-keeper. As the hour drew near, I said, 'Smith, do you still want to be killed?' because the command ordered me not to kill anybody who didn't want to be killed. Smith nodded his head. When it was just 12 o'clock, I said, 'Smith, get up and stand on the altar.' I grabbed my dirk (an eight-inch case knife) and stabbed him like this. Smith fell off the altar and started to groan and tried to get up.
The saltwater fishkeeping hobby has expanded, over recent years, to include reef tanks, which are fish tanks that include large amounts of live rock on which coral is allowed to grow and spread. These tanks are either kept in a natural-like state, with algae (sometimes in the form of an algae scrubber) and a deep sand bed providing filtration, or as "show tanks", with the rock kept largely bare of the algae and microfauna that would normally populate it, in order to appear neat and clean. The most popular kind of coral kept is soft coral, especially zoanthids and mushroom corals, which are especially easy to grow and propagate in a wide variety of conditions, because they originate in enclosed parts of reefs where water conditions vary and lighting may be less reliable and direct. More serious fishkeepers may keep small polyp stony coral, which is from open, brightly lit reef conditions and therefore much more demanding, while large polyp stony coral is a sort of compromise between the two.
The Scientific Research Publishing (SCIRP) is a predatory academic publisher of open-access electronic journals, conference proceedings, and scientific anthologies that are of questionable quality. As of December 2014, it offered 244 English-language open-access journals in the areas of science, technology, business, economy, and medicine. The company has been accused of using email spam to solicit papers for submission. Although it has an address in southern California, according to Jeffrey Beall it is a Chinese operation. In 2014 there was a mass resignation of the editorial board of one of the company's journals, Advances in Anthropology, with the outgoing editor-in-chief saying of the publisher "For them it was only about making money. We were simply their 'front'."
=== 2010s === Stanton was elected into the Essendon leadership group for the 2010 season. Stanton amassed 477 possessions and kicked 13 goals in 20 games for an Essendon team which won seven matches and lost fifteen in a year that would see their coach, Matthew Knights, sacked one day after the conclusion of the regular season. Stanton polled six votes in the Brownlow Medal and finished fifth in the 2010 Crichton Medal with 167 votes. Stanton continued to improve during the year. Stanton led the club in kicks and handballs received and was in the top five for marks, handballs, inside-50s, rebound-50s and loose-ball gets. Into his ninth AFL season and in the Essendon leadership group, Stanton finished second in the 2011 Crichton Medal behind David Zaharakis. He played his 150th AFL game against Melbourne in Round 11. Wearing the number 5, his running and ability to accumulate possessions contributed to every victory during the 2012 season. He has now polled a career high 14 votes in the 2012 Brownlow Medal. In Round 6 of the 2012 AFL season, Stanton collected a record 193 Dream Team points in Essendon's win against the Brisbane Lions at Docklands Stadium. His statistics included: 39 disposals (from 32 kicks and 7 handballs), 17 marks and 8 tackles. As of 2015, it remains the highest Dream Team score by a midfielder. Stanton played his 200th game in Round 20, 2013 against West Coast at Etihad Stadium.
Sources: en.wikipedia.org
=== Europe === Skin whitening practices have been documented in ancient Greece and Rome. Bleaching cosmetics often incorporated white lead carbonate and mercury as lightening agents. These products were ultimately known to cause skin erosion. Skin whitening was frequently documented during the Elizabethan era. Queen Elizabeth's own usage of skin lighteners became a prominent standard of beauty. According to medieval historians, light skin was an indicator of aristocracy and higher socioeconomic class, as laborers were more frequently exposed to outdoor sunlight. Men and women lightened their skin superficially and chemically, using white powder and Venetian ceruse, respectively. Venetian ceruse consisted of a lead and vinegar mixture, known to cause hair loss, skin corrosion, muscle paralysis, tooth deterioration, blindness, and premature aging. Venetian ceruse was also reported as a source of lead poisoning. Lye and ammonia, found in other skin whiteners, compounded the toxic effects of lead. Other practices done in the name of skin whitening included washing one's face in urine and ingesting wafers of arsenic.
While the "ness team" began moving to Bawdsey, the Orfordness site remained in use. This proved useful during one demonstration when the new system recently completed at Bawdsey failed. The next day, Robert Hanbury-Brown and the new recruit Gerald Touch started up the Orfordness system and were able to run the demonstrations from there. The Orfordness site was not closed until 1937.
Subsequent lodges were formed in Washington, D.C., and Philadelphia in 1866 and 1867 respectively. By the late 1890s, the Order was said to have members in almost every state of the Union. State divisions were called Grad Lodges, and the national organization was controlled by a Supreme Lodge of the United States that met "one the first hour of every leap year." Lodge rooms were called Smithies, the presiding officer was titled Sun, the second-in-command was the moon, and other officials had names based on the planets and other bodies in the firmament. The order worked nine degrees, six lower, called the Free Smiths, and three higher degrees - Grand Marshal, Grand Master, and Cavalier - which were open to members who had been in the Order longer and were entitled to wear colored sashes and swords. The motto of the order was Truth, Fidelity, and Security. The order also paid sick and death benefits. Correspondence sent to Baltimore in May 1923 by Arthur Preuss went unanswered. Bavarian National Association of North America - Founded 1884, incorporated in New York. In 1923 the Association had c.3,500 members in 56 lodges; membership "not strictly limited to", natives of Bavaria and their descendants. "Supreme Office" at 749 Broadway, Buffalo, New York. Merged with Unity Life and Accident Insurance Association in 1934. GUG Germania - Gegenseite Unterstutzungsgeselshaft Germania, founded in 1888 and incorporated the same year in Wisconsin, in which state they confined their operations.
==== Basic metabolic studies ==== Biochemical studies are performed to screen for imbalances of metabolites in the bodily fluid, usually the blood (plasma/serum) or urine, but also in cerebrospinal fluid (CSF). Specific tests of enzyme function (either in leukocytes, skin fibroblasts, liver, or muscle) are also employed under certain circumstances. In the US, the newborn screen incorporates biochemical tests to screen for treatable conditions such as galactosemia and phenylketonuria (PKU). Patients suspected to have a metabolic condition might undergo the following tests:
Sources: en.wikipedia.org
Dihexa has been proposed to act through HGF and c-Met signaling. This pathway is linked to synapse formation and cellular growth. Direct binding and the precise molecular step remain uncertain.
No published human clinical trials are available for dihexa. Its safety and effectiveness in people are therefore unknown. Most available evidence comes from animal and cell studies.
Preclinical studies often measure dendritic spine density and synaptic protein levels. Behavioral tests include maze learning and avoidance tasks. These endpoints are indirect and do not establish clinical benefit.
It is a synthetic peptide analog of angiotensin IV studied mainly in laboratory and animal research. It is not an approved medicine. Human clinical data are limited.